Access brought to you by: LOCKSS
Login
Time to Regained Low Disease Activity After Flare in Patients Who Stopped TNFi Therapy
TNFi, tumor necrosis factor inhibitor.
Reproduced with permission from HE Vonkeman, MD, PhD.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.